Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells

논문상세정보

' Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells' 의 참고문헌

  • b1-integrin-dependent migration of microglia response to neuron-released a-synuclein
    김창연 [2014]
  • alphaSynucleinopathy phenotypes
    McCann, H. [2014]
  • alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
    Hansen, C. [2011]
  • Ultrasonication-based rapid amplification of alpha-synuclein aggregates in cerebrospinal fluid
    Kakuda, K. [2019]
  • Ultrasensitive detection of aggregated alpha-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay : new high-throughput neuroimmune biomarker assay for Parkinsonian disorders
    Manne, S. [2019]
  • Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons
  • Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia
    Fellner, L. [2013]
  • Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology
    Dzamko, N. [2017]
  • The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
  • The many faces of alphasynuclein: from structure and toxicity to therapeutic target
  • The function of alpha-synuclein
  • Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
    권소민 [2019]
  • TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
    Shao, Q. H. [2019]
  • TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model
    Campolo, M. [2019]
  • Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
    Xiaobo Mao [2016]
  • Non-cell-autonomous actions of alphasynuclein : implications in glial synucleinopathies
    Lim, S. [2018]
  • New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy
  • Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
    Kim, C. [2013]
  • Neuroinflammation as a common feature of neurodegenerative disorders
  • Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alphasynuclein
    Zhang, W. [2007]
  • LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies
  • Invited article: nervous system pathology in sporadic Parkinson disease
    Braak H [2008]
  • Inclusion formation and neuronal cell death through neuronto-neuron transmission of alpha-synuclein
  • Immunotherapy targeting Toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating alpha-synuclein transmission and neuroinflammation
    Kim, C. [2018]
  • Hypoestoxide reduces neuroinflammation and alpha-synuclein accumulation in a mouse model of Parkinson’s disease
    Kim, C. [2015]
  • Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1beta-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression
    Fields, J. [2013]
  • Extracellular alpha-synuclein—a novel and crucial factor in Lewy body diseases
    Lee, H. J. [2014]
  • Exposure to bacterial endotoxin generates a distinct strain of alpha-synuclein fibril
    Kim, C. [2016]
  • Exosomal cell-to-cell transmission of alpha synuclein oligomers
  • ESCRT-mediated uptake and degradation of brain-targeted alpha-synuclein single chain antibody attenuates neuronal degeneration in vivo
    Spencer, B. [2014]
  • Dopaminergic loss and inclusion body formation in alphasynuclein mice : implications for neurodegenerative disorders
    Masliah, E. [2000]
  • Cryo-EM structure of alpha-synuclein fibrils
  • Controlling the mass action of alpha-synuclein in Parkinson’s disease
    Kim, C. [2008]
  • Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway
    Lee, H. J. [2004]
  • Clearance and deposition of extracellular alpha-synuclein aggregates in microglia
    Lee, H. J. [2008]
  • Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type
    Ihse, E. [2017]
  • Cell Responses to Extracellular α-Synuclein
  • Antagonizing neuronal Toll-like receptor 2 prevents synucleinopathy by activating autophagy
    Kim, C. [2015]
  • Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2